Focus: Singular Genomics is a genomics-focused biotechnology company headquartered in San Diego specializing in sequencing and genomic analysis technologies. The company operates in the pre-revenue or early-stage biotech space with limited public commercial footprint.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Singular Genomics presents a high-risk, high-reward opportunity suited for early-career scientists willing to build infrastructure at a stealth-stage genomics platform with unproven commercial viability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Singular Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Singular Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles